!

A recent study shows:

COVID-19, particularly in the later
complicated stages, represents and can
be managed as endothelial disease*

What if

you could identify patients who were infected by COVID-19
as high risk for complications early?

Would you treat them differently

?

For limited time!

we offer a unique proposal for EndoPAT system

>

$

ONLY

55

Cost Per
Test
(CPT)
model**

To receive this unique proposal please complete the form below:

*Reference: COVID-19 is, in the end, an endothelial disease, Peter Libby and Thomas Luscher, Eu-ropean Heart Journal (2020) 41, 3038–3044

** Subject to the provisions, Itamar Medical will rent per test EndoPAT Devices to the client during the defined term. $55 includes $8 EndoPAT rent fee and $47 EndoPAT probe fee. The term should not be less than 3 months and not more than 12 months and there is a minimum of 60 probes per Endo-PAT unit purchase requirement. This promotion valid only for US customers until April 30, 2021.